Abstract
In this issue of Blood, Crudele et al describe a novel study of adeno-associated virus (AAV) vector-mediated gene therapy that induced immune tolerance to factor IX (FIX) in a hemophilia B (HB) dog with previously formed anti-FIX inhibitor antibodies (IAs).1
Cite
CITATION STYLE
APA
Koeberl, D. D. (2015, March 5). A natural choice for hemophilia B. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2015-01-622506
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free